Fingerprint
Dive into the research topics of 'Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial
Javier Cortés, Hope S. Rugo, Chris Twelves, Ahmad Awada, Edith A. Perez, Seock Ah Im, Carol Zhao, Ute Hoch, Denise Tomkinson, James Buchanan, Mary Tagliaferri, Alison Hannah, Joyce O’Shaughnessy
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations